Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Xtant Medical Holdings (XTNT) over the last 17 years, with Q3 2025 value amounting to $4.7 million.

  • Xtant Medical Holdings' Cash from Investing Activities rose 33290.19% to $4.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 million, marking a year-over-year increase of 14842.95%. This contributed to the annual value of -$3.7 million for FY2024, which is 8495.0% up from last year.
  • As of Q3 2025, Xtant Medical Holdings' Cash from Investing Activities stood at $4.7 million, which was up 33290.19% from -$317000.0 recorded in Q2 2025.
  • In the past 5 years, Xtant Medical Holdings' Cash from Investing Activities registered a high of $4.7 million during Q3 2025, and its lowest value of -$17.4 million during Q1 2023.
  • In the last 5 years, Xtant Medical Holdings' Cash from Investing Activities had a median value of -$483000.0 in 2021 and averaged -$1.5 million.
  • As far as peak fluctuations go, Xtant Medical Holdings' Cash from Investing Activities crashed by 435549.87% in 2023, and later skyrocketed by 33290.19% in 2025.
  • Over the past 5 years, Xtant Medical Holdings' Cash from Investing Activities (Quarter) stood at -$595000.0 in 2021, then rose by 29.08% to -$422000.0 in 2022, then crashed by 448.1% to -$2.3 million in 2023, then skyrocketed by 75.49% to -$567000.0 in 2024, then surged by 925.22% to $4.7 million in 2025.
  • Its Cash from Investing Activities stands at $4.7 million for Q3 2025, versus -$317000.0 for Q2 2025 and -$1.1 million for Q1 2025.